To validate upregulation of these effector cytokines at the protein level, CD8+ T cells isolated from liquid biopsies of immunotherapy-responsive or -resistant melanoma patients were treated with nPKC-θi2 in vitro before activation with PMA and ionomycin (Figure 7D). Here, CD8A is linked to melanoma.